Revvity (RVTY) revenue

Revenue · fiscal 2025
$2.86B

Revvity (RVTY) reported revenue of $2.86B in fiscal 2025 (the year ended December 31, 2025). That is 3.7% higher than the $2.76B of fiscal 2024. Figures as of 18 Nov 2026, 07:39 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$2.86B
Change on fiscal 2024
+3.7%
Highest on record
$3.83Bfiscal 2022
Lowest on record
$1.55Bfiscal 2010
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Revvity revenue, in more detail

Across the 18 fiscal years on record (2008–2025), the highest was $3.83B in fiscal 2022 and the lowest $1.55B in fiscal 2010.

History · 18 fiscal years

Revenue by fiscal year

Revvity revenue, year by year

Revvity (RVTY) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$2.86B 3.7% up
2024$2.76B 0.2% up
2023$2.75B 16.9% down
2022$3.31B—
2022$3.83B 43.7% up
2021$2.66B—
2019$2.88B 3.8% up
2018$2.78B 23.1% up
2017$2.26B—
2017$2.12B 0.5% up
2016$2.10B—
2014$2.24B 3.7% up
2013$2.16B 2.0% up
2012$2.12B—
2012$1.92B 12.6% up
2011$1.70B 9.9% up
2010$1.55B—
2008$1.66B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of Revvity and comparable companies
CompanyRevenueFiscal year
Medpace Holdings MEDP$2.53B2025
Revvity RVTY$2.86B2025
Exelixis EXEL$2.32B2025
Charles River Laboratories International CRL$4.02B2025
Neurocrine Biosciences NBIX$2.86B2025
Ascendis Pharma ASND€720.13M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on RVTY

Revvity, figure by figure

Revvity (RVTY) overview: price, valuation and scorecardAll health care companies by market value

Revvity revenue: questions and answers

What is Revvity's revenue?

Revvity (RVTY) reported revenue of $2.86B in fiscal 2025 (the year ended December 31, 2025). That is 3.7% higher than the $2.76B of fiscal 2024.

What are the highest and lowest revenue figures on record for Revvity?

Across the 18 fiscal years on record (2008–2025), the highest was $3.83B in fiscal 2022 and the lowest $1.55B in fiscal 2010.

How is Revvity's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Revvity (RVTY) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/RVTY/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.